Latanoprostene bunod (Vyzulta )

Original post, click here

Generic Name: Latanoprostene bunod

Brand Name: Vyzulta

Manufacturer: Bausch & Lomb Incorporated, a subsidiary of Valeant Canada LP

Indications: Open-angle glaucoma or ocular hypertension

Manufacturer Requested Reimbursement Criteria1:

For the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Submission Type: New

Project Status: Pending

Call For Patient Input: October 24, 2018

Patient Input Closed: December 12, 2018

Anticipated Date: November 21, 2018

Biosimilar: No

Fee Schedule: Pending

  1. The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.

Submit Feedback